...
首页> 外文期刊>International Journal of Research in Medical Sciences >Recent trends in the antimicrobial susceptibility patterns of urinary pathogens in type II diabetes mellitus
【24h】

Recent trends in the antimicrobial susceptibility patterns of urinary pathogens in type II diabetes mellitus

机译:II型糖尿病患者尿液病原体抗菌药敏模式的最新趋势

获取原文
           

摘要

Background: Diabetes mellitus is one of the most frequently encountered diseases in clinical practice and since the diabetic patients are at an increased risk of infections specially those of the urinary tract it is imperative for a physician to be aware of the prevalence and antibiotic susceptibility patterns of urinary pathogens. Thus, in this study we assess the recent trends in antimicrobial susceptibility patterns of urinary pathogens in type II diabetes mellitus. Methods: Ninety-three eligible type II diabetes mellitus cases without genitourinary symptoms or abnormalities along with 93 non-diabetic healthy controls were recruited. Mid-stream urine was collected after taking informed consent and each sample tested using the dipstick, microscopy and culture techniques. Isolates were identified using standard biochemical tests. Results: Prevalence of asymptomatic bacteriuria (ASB) in our study was found to be 34.4% among cases of type II diabetes mellitus while it was 6.45% among non-diabetic healthy controls . E. coli was the most common urinary pathogen isolated . E. coli susceptibility towards amikacin was 85.71%, towards ceftriaxone and nitrofurantoin was 71.73% and for meropenem and doxycycline 66.67% susceptibility was observed. In the one case where pseudomonas was cultured, it was susceptible to meropenem, gentamycin, cefoperazone-sulbactum and cefuroxime. In an isolated case where Proteus species was grown, it showed susceptibility to meropenem, norfloxacin, levofloxacin and co-trimoxazole. Enterobacter species which was grown, showed susceptibility to meropenem, vancomycin, amikacin, nitrofurantoin, norfloxacin, levofloxacin and co-trimoxazole. Gram positive bacteria mainly showed susceptibility to ceftriaxone, teicoplanin, vancomycin and doxycycline. Conclusions: The prevalence of bacteriuria is significantly higher in diabetics as compared to non-diabetics and with the recent trends suggestive of emerging resistance among urinary pathogens to some of the commonly used anti-microbials it is of utmost importance to carry out regular surveillance of bacterial profile and their anti-microbial susceptibilities to formulate updated guidelines for effectively treating urinary infections in diabetic patients.
机译:背景:糖尿病是临床实践中最常遇到的疾病之一,并且由于糖尿病患者尤其是尿路感染者的感染风险增加,因此医生必须了解糖尿病的患病率和抗生素敏感性模式。尿中的病原体。因此,在这项研究中,我们评估了II型糖尿病患者尿中病原菌的抗菌药敏模式的最新趋势。方法:收集了93例无泌尿生殖系统症状或异常的合格II型糖尿病患者,以及93名非糖尿病健康对照者。在征得知情同意后收集中游尿液,并使用量油尺,显微镜和培养技术对每个样品进行测试。使用标准生化测试鉴定出分离物。结果:在我们的研究中,无症状细菌尿症(ASB)的患病率在II型糖尿病患者中占34.4%,而在非糖尿病健康对照组中则为6.45%。大肠杆菌是分离出的最常见的尿病原体。大肠杆菌对丁胺卡那霉素的敏感性为85.71%,对头孢曲松和呋喃妥因的敏感性为71.73%,对美罗培南和强力霉素的敏感性为66.67%。在培养假单胞菌的一种情况下,它易受美罗培南,庆大霉素,头孢哌酮-硫酸和头孢呋辛的影响。在变形杆菌属生长的孤立病例中,它对美洛培南,诺氟沙星,左氧氟沙星和复方新诺明易感。生长的肠杆菌对美罗培南,万古霉素,阿米卡星,硝基呋喃妥因,诺氟沙星,左氧氟沙星和复方新诺明易感。革兰氏阳性细菌主要表现出对头孢曲松,替考拉宁,万古霉素和强力霉素的敏感性。结论:与非糖尿病患者相比,糖尿病患者中细菌尿的患病率明显更高,并且最近的趋势表明泌尿病原体对某些常用抗微生物药产生了耐药性,因此对细菌进行定期监测至关重要。概况及其抗微生物药性,以制定有效治疗糖尿病患者尿路感染的最新指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号